Cocrystal Pharma, Inc. Common Stock (COCP)
Cocrystal Pharma, Inc. (COCP) is a biotechnology company focused on developing antiviral therapeutics and diagnostics. It leverages its expertise in structure-based drug design and proprietary platforms to create treatments for viral infections such as hepatitis, influenza, and COVID-19. The company's approach combines scientific innovation with targeted antiviral development to address significant unmet medical needs.
Company News
Cocrystal Pharma presented CDI-988, a potential first oral antiviral for norovirus infection, at the International Calicivirus Conference. The drug shows promising broad-spectrum activity and has received FDA clearance for a Phase 1b human challenge study.
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Cocrystal Pharma (NASDAQ:COCP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 0 0 0 0 These 4 analysts have an average price target of $12.0 versus the current...
Penny stocks to watch this week under $3. The post Penny Stocks To Buy Now? 4 Under $3 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.